USPTO serial 79360563
IPONATIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- PERITZ, SARAH L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IPONATIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable pharmaceuticals for treatment of anaphylactic reactions; Metallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Vaccines; Antibiotic tablets; Allergy tablets; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions in the nature of serums for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Demineralised water for medical purposes; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Chinese medicine nostrum in the nature of natural remedy preparation, namely, medicinal herbs; Diagnostic kits comprised of medical diagnostic reagents for testing of bodily fluids for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting immune system and respiratory system diseases, cancer, infectious diseases, inflammatory disorders, and oncological disorders; Purified biochemical medical diagnostic reagents, namely, protein arrays for medical diagnosis purposes, enzymes for medical purposes, and fluorescent surgical dyes; Biological preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Biochemical drugs in the nature of biochemical drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemical-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for medical or veterinary purposes; Reagents for medical use; Reagents for use in medical genetic testing; Medical diagnostic reagents; Enzyme preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Rat poison; Medical dressings; Materials for artificial teeth; Diapers for pets; Reagent paper for medical purposes; Chemical preparations for the diagnosis of pregnancy; Preparations for detecting genetic predispositions for medical purposes; Immunoassay reagents for medical use; Genetic identity tests comprised of reagents for medical purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for veterinary purposes | ACTIVE | — |
| 009 | Downloadable computer operating programs; Recorded computer operating software; Downloadable software application for mobile phones, namely, downloadable software for use in operating polymerase chain reaction (PCR) instruments; Downloadable software application for mobile phones, namely, downloadable software for DNA and gene analysis; Data processing apparatus; Biometric scanners; Chemistry apparatus and instruments, namely, liquid test tubes and containers in the nature of laboratory glassware beakers, solvent reservoirs, and chromatography columns for laboratory use; Chromatography apparatus for laboratory use; MRI apparatus, not for medical purposes; Automatic ion exchange chromatography apparatus for laboratory use; Polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction, not for medical purposes; DNA chips; Electronic devices for analyzing genome information for laboratory use; Nucleic acid sequencers for scientific purposes; Laboratory devices for detecting genetic sequences; Bio-chips for research or scientific purposes | ACTIVE | — |
| 010 | Apparatus for DNA and RNA testing for medical purposes; Blood testing apparatus; Probes for medical purposes; analysers for bacterial identification for medical purposes; Diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus for use with computer displays and computer monitors for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; Medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes; Surgical apparatus and instruments; Genetic testing apparatus for medical purposes; Apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; Body composition analyzers for medical purposes; Radiotherapy apparatus; Physiotherapy apparatus, namely, body rehabilitation apparatus for medical use; Lasers for medical purposes; Orthopaedic belts; Orthopaedic bandages; Orthopaedic footwear; Suture materials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks owned by Sansure Biotech Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named IPONATIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 17, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 17, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 14, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 14, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 14, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 14, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 21, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 21, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 25, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 19, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |